Conference Reports for NATAP

The International Liver Congress™ EASL - European Association for the Study of the Liver 2019 April 10-14 Vienna Austria Back

EDP-514, a Novel HBV Core Inhibitor with Potent Antiviral Activity both In Vitro and In Vivo       EASL 2019 Reported by Jules Levin